Rockefeller Capital Management’s Usana Health Sciences USNA Stock Holding History

Rockefeller Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87	Sell	5 -12	-71%	-$238	﹤0.01%	4641
2025 Q4	$334	Sell	17 -5	-23%	-$104	﹤0.01%	4562
2025 Q3	$606	Buy	+22	New	+$677	﹤0.01%	4252
2023 Q1	–	Sell	-4	Closed	–	–	3799
2022 Q4	$0	Hold	4	–	–	﹤0.01%	4229
2022 Q3	$0	Sell	4 -29	-88%	-$1.92K	﹤0.01%	4394
2022 Q2	$2K	Buy	33 +29	+725%	+$2.16K	﹤0.01%	3843
2022 Q1	$0	Buy	+4	New	+$361	﹤0.01%	4074
2021 Q4	–	Sell	-27	Closed	-$2K	–	3995
2021 Q3	$2K	Buy	+27	New	+$2.6K	﹤0.01%	3487
2021 Q1	–	Sell	-3,660	Closed	-$282K	–	3397
2020 Q4	$282K	Hold	3,660	–	–	﹤0.01%	1083
2020 Q3	$269K	Hold	3,660	–	–	﹤0.01%	956
2020 Q2	$269K	Hold	3,660	–	–	﹤0.01%	874
2020 Q1	$211K	Hold	3,660	–	–	﹤0.01%	803
2019 Q4	$287K	Hold	3,660	–	–	﹤0.01%	691
2019 Q3	$250K	Hold	3,660	–	–	﹤0.01%	583
2019 Q2	$291K	Hold	3,660	–	–	﹤0.01%	522
2019 Q1	$307K	Hold	3,660	–	–	﹤0.01%	544
2018 Q4	$431K	Buy	+3,660	New	+$423K	0.01%	339

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Capital Management's USNA Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Usana Health Sciences (USNA) stake by 71% in Q1 2026, selling an estimated $238 and leaving 5 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #4641.

Rockefeller Capital Management first reported a position in USNA in Q4 2018 and has held it in 17 quarters since. The position peaked at $431K in Q4 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

Rockefeller Capital Management held 5 shares of Usana Health Sciences worth $87 as of Q1 2026.
Rockefeller Capital Management sold 12 Usana Health Sciences shares in Q1 2026, an estimated $238.
Usana Health Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4641 holding.
Rockefeller Capital Management first reported a position in Usana Health Sciences in Q4 2018 and has held it in 17 quarters since.
Rockefeller Capital Management's Usana Health Sciences position peaked at $431K in Q4 2018.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.